These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38083824)
1. Correction to "A new computational approach, based on images trajectories, to identify the subjacent heterogeneity of sperm to the effects of ketanserin". Cytometry A; 2024 Feb; 105(2):157. PubMed ID: 38083824 [No Abstract] [Full Text] [Related]
2. A new computational approach, based on images trajectories, to identify the subjacent heterogeneity of sperm to the effects of ketanserin. Rodríguez-Martínez EA; Rivas CU; Ayala ME; Blanco-Rodríguez R; Juarez N; Hernandez-Vargas EA; Aragón A Cytometry A; 2023 Aug; 103(8):655-663. PubMed ID: 36974731 [TBL] [Abstract][Full Text] [Related]
16. Ketanserin and the cardiovascular response to intubation: a preliminary report. Murray WB; Daniel CH Eur J Anaesthesiol; 1987 Nov; 4(6):401-9. PubMed ID: 3328682 [TBL] [Abstract][Full Text] [Related]
17. Ketanserin in essential hypertension: effects during rest and exercise. Persson B; Hedner T; Berglund G Eur J Clin Pharmacol; 1983; 25(3):307-12. PubMed ID: 6628517 [TBL] [Abstract][Full Text] [Related]
18. Effects of ketanserin tartrate on serum lipids in patients with essential hypertension. Nakamura H; Hirata F; Yasugi T; Mizuno M; Saito E; Ishikawa T; Tada N; Nakaya N; Homma Y; Takeuchi I Drugs; 1988; 36 Suppl 1():25-34. PubMed ID: 3071460 [TBL] [Abstract][Full Text] [Related]
19. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618 [TBL] [Abstract][Full Text] [Related]